Sheldon Mink

637 total citations
9 papers, 483 citations indexed

About

Sheldon Mink is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Sheldon Mink has authored 9 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Sheldon Mink's work include Virus-based gene therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Cancer therapeutics and mechanisms (1 paper). Sheldon Mink is often cited by papers focused on Virus-based gene therapy research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers) and Cancer therapeutics and mechanisms (1 paper). Sheldon Mink collaborates with scholars based in United States and Poland. Sheldon Mink's co-authors include Ke Shuai, Kelly A. Wong, Natalie Stein, Hong Wu, Bin Liu, Paul W. Dempsey, David B. Agus, Anjali Jain, Amanda Hodge and Wenxuan Zhang and has published in prestigious journals such as Cell, Nature Immunology and Cancer Research.

In The Last Decade

Sheldon Mink

9 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheldon Mink United States 5 262 248 197 110 51 9 483
Joana Carvalho United Kingdom 11 356 1.4× 207 0.8× 121 0.6× 105 1.0× 33 0.6× 13 552
Christelle P El-Haibi United States 7 179 0.7× 245 1.0× 152 0.8× 80 0.7× 50 1.0× 11 487
Alice Melotti Italy 6 242 0.9× 267 1.1× 229 1.2× 93 0.8× 56 1.1× 7 609
Margaret L. Axelrod United States 7 177 0.7× 312 1.3× 273 1.4× 87 0.8× 81 1.6× 17 514
Tim Fessenden United States 8 190 0.7× 247 1.0× 283 1.4× 78 0.7× 93 1.8× 9 517
Leah Schmidt United States 4 268 1.0× 409 1.6× 336 1.7× 131 1.2× 78 1.5× 5 706
Kijong Yi South Korea 10 244 0.9× 204 0.8× 160 0.8× 144 1.3× 115 2.3× 12 578
Claire Mazumdar United States 4 241 0.9× 289 1.2× 316 1.6× 90 0.8× 36 0.7× 4 585
Oriana E. Hawkins United States 16 277 1.1× 290 1.2× 326 1.7× 62 0.6× 54 1.1× 19 687
Mirco Compagnone Italy 13 296 1.1× 234 0.9× 115 0.6× 56 0.5× 25 0.5× 23 479

Countries citing papers authored by Sheldon Mink

Since Specialization
Citations

This map shows the geographic impact of Sheldon Mink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheldon Mink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheldon Mink more than expected).

Fields of papers citing papers by Sheldon Mink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheldon Mink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheldon Mink. The network helps show where Sheldon Mink may publish in the future.

Co-authorship network of co-authors of Sheldon Mink

This figure shows the co-authorship network connecting the top 25 collaborators of Sheldon Mink. A scholar is included among the top collaborators of Sheldon Mink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheldon Mink. Sheldon Mink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Thakur, Garima, et al.. (2025). A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors. Molecular Therapy — Methods & Clinical Development. 33(2). 101441–101441. 3 indexed citations
2.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Single-use chromatographic clarification to eliminate endonuclease treatment in production of recombinant adeno-associated viral vectors. Separation and Purification Technology. 354. 128557–128557. 3 indexed citations
3.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2024). Improving process efficiency to reduce cost-of-goods per dose in manufacturing of recombinant AAVs. Cell and Gene Therapy Insights. 10(3). 479–499. 1 indexed citations
4.
Thakur, Garima, Sheldon Mink, Hanne Bak, & Andrew D. Tustian. (2023). Opportunities to implement continuous processing in production of recombinant adeno-associated viral vectors. Cell and Gene Therapy Insights. 9(3). 563–579–563–579. 2 indexed citations
5.
Jain, Anjali, Elicia Penuel, Sheldon Mink, et al.. (2010). HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation. Cancer Research. 70(5). 1989–1999. 56 indexed citations
6.
Mink, Sheldon, et al.. (2010). Cancer-Associated Fibroblasts Derived from EGFR-TKI–Resistant Tumors Reverse EGFR Pathway Inhibition by EGFR-TKIs. Molecular Cancer Research. 8(6). 809–820. 72 indexed citations
7.
Mink, Sheldon, Amanda Hodge, David B. Agus, Anjali Jain, & Mitchell E. Gross. (2010). Beta‐2‐microglobulin expression correlates with high‐grade prostate cancer and specific defects in androgen signaling. The Prostate. 70(11). 1201–1210. 12 indexed citations
8.
Liu, Bin, Yonghui Yang, Rachel R. Ogorzalek Loo, et al.. (2007). Proinflammatory Stimuli Induce IKKα-Mediated Phosphorylation of PIAS1 to Restrict Inflammation and Immunity. Cell. 129(5). 903–914. 130 indexed citations
9.
Liu, Bin, Sheldon Mink, Kelly A. Wong, et al.. (2004). PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nature Immunology. 5(9). 891–898. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joana Carvalho Breakdown of academic impact, for papers by Christelle P El-Haibi Breakdown of academic impact, for papers by Alice Melotti Breakdown of academic impact, for papers by Margaret L. Axelrod Breakdown of academic impact, for papers by Tim Fessenden Breakdown of academic impact, for papers by Leah Schmidt Breakdown of academic impact, for papers by Kijong Yi Breakdown of academic impact, for papers by Claire Mazumdar Breakdown of academic impact, for papers by Oriana E. Hawkins Breakdown of academic impact, for papers by Mirco Compagnone
Rankless by CCL
2026